Bremelanotide

Is Bremelanotide FDA-approved?

Approved by the FDA. A licensed clinician has to decide it is right for you and prescribe it. Vyleesi is FDA-approved for a specific indication and supplied by prescription. Research-vendor PT-141 is not the approved product.

As of September 28, 2026.

What does the evidence say about Bremelanotide?

Randomized trials support the approved indication; they do not validate unapproved RUO formulations or other promoted uses.

What are the risks and side effects of Bremelanotide?

• The label warns about temporary blood-pressure increases and reduced heart rate.
• Nausea, flushing and headache are common.
• It is not recommended for people with uncontrolled high blood pressure or known cardiovascular disease.
• An RUO vial is not interchangeable with Vyleesi.

What should you ask a clinician about Bremelanotide?

• Does my situation match the FDA-approved indication?
• Could my blood pressure or medications make it unsafe?

These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Where can I get Bremelanotide?

2 providers list Bremelanotide on DiscoverMedica, lowest listed price first.

† Prices as listed by the provider when we checked; they change.

How much does Bremelanotide cost?

The listed price is $130 a month, from 1 provider, as checked October 7, 2026.

Prices as listed by the provider when we checked; they change. Membership or consult fees may be separate; see each provider.

Sources

• DailyMed: Vyleesi prescribing information
• FDA: Vyleesi approval information

Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.